依米康(300249.SZ):三大運營商一直都是公司重要客户
格隆匯6月9日丨有投資者在投資者互動平台向依米康(300249.SZ)提問,“6月5日,中國移動、中國電信、中國聯通三大運營商聯合發佈了《電信運營商液冷技術白皮書》(以下簡稱“白皮書”)。請問貴公司與三大運營商有合作嗎?”
公司回覆稱,三大運營商一直都是公司重要客户,公司可為三大運營商提供數據中心關鍵設備、工程技術、物聯軟件、智慧服務四大綜合服務。公司重視以三大運營商為代表的重要客户,也期望能抓住行業大發展的機遇,持續提升算力基礎設施全生命週期綠色解決方案的能力,不斷挖掘可服務點位,快速響應客户需求,做強做大主業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.